NuvoAir

Boston, United States

NuvoAir is a value-based specialty management platform transforming the diagnosis and management of chronic heart and lung conditions.

$11.0M raised

Jan 2022

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has NuvoAir raised?

NuvoAir has raised $11.0M in total funding. The most recent round was Series A. The last funding was announced in January 2022.

Who are NuvoAir's investors?

NuvoAir's investors include Novartis, KAYA, AlbionVC, Hikma Ventures, Industrifonden.

Where is NuvoAir headquartered?

NuvoAir is headquartered in Boston, United States.

What does NuvoAir do?

NuvoAir is a value-based specialty management platform transforming the diagnosis and management of chronic heart and lung conditions.

What stage is NuvoAir at?

NuvoAir is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 19, 2022.

MLA

"NuvoAir — Funding & Investors." VCBacked, January 19, 2022, https://www.vcbacked.co/company/nuvoair. Accessed July 5, 2026.

APA

VCBacked. (2022). NuvoAir — Funding & Investors. Retrieved July 5, 2026, from https://www.vcbacked.co/company/nuvoair

Wikipedia (cite web)

{{cite web |title=NuvoAir — Funding & Investors |url=https://www.vcbacked.co/company/nuvoair |website=VCBacked |access-date=July 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 19, 2022.